Jungen Christiane, Rattka Manuel, Bohnen Jan, Mavrakis Evangelos, Vlachopoulou Dimitra, Dorna Sebastian, Rudolph Isabel, Kohn Christina, Dobrev Dobromir, Rassaf Tienush, Mathew Shibu
Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Essen, Germany.
Department of Clinical Medicine - Clinical Department for Cardiology, University Medical Center, Technical University of Munich, Munich, Germany.
Int J Cardiol Heart Vasc. 2024 Oct 1;55:101516. doi: 10.1016/j.ijcha.2024.101516. eCollection 2024 Dec.
Pulmonary vein isolation (PVI) using pulsed field ablation (PFA) or cryoballoon ablation (CBA) are commonly used single-shot techniques for the treatment of patients with atrial fibrillation (AF). The number of overweight (BMI 25-30 kg/m) and obese (BMI>30 kg/m) patients undergoing PVI is increasing, but data on this patient population is limited.
Consecutive AF patients with a BMI ≥25 kg/m undergoing PFA- or CBA-PVI were included in this retrospective analysis. Baseline characteristics, procedural parameters and 1-year AF-freedom were retrospectively analyzed and compared for both ablation modalities.
Of 115 patients (66 % men, 64 years [IQR: 58-71 years], 57 % overweight and 43 % obese) PFA- was performed in 68 % and CBA-PVI in 32 %. Contrast-dye volume (PFA: 80 ml [IQR: 60 - 117 ml] vs. CBA: 130 ml [IQR: 95 - 200 ml], =0.001) and radiation exposure (PFA: 2196 cGy·cm [IQR: 1398 - 2973 cGy·cm] vs. CBA: 3239 cGy·cm [IQR: 1288 - 5062 cGy·cm], =0.009) was lower in patients undergoing PFA-PVI. Logistic regression analysis identified obesity (OR: 5.58, 95 % CI: 1.63-19.06; =0.006) and CBA-PVI (OR: 12.93, 95 % CI: 3.51-47.68; 0.001) to be associated with increased radiation exposure. Both techniques were comparably safe (PFA: 4 % vs. CBA: 0 %; =0.3). The median follow-up time was 145 days [IQR: 103 - 294 days]. AF-freedom after 1-year was similar in overweight (82 %) and obese patients (67 %) (HR: 0.61; 95 % CI: 0.29-1.28; =0.19) as well as in PFA- and CBA-PVI patients (76 % vs. 76 %, HR: 1.37; 95 % CI: 0.63-2.99; =0.42).
Overweight and obese patients undergoing PFA-PVI had lower contrast-dye volume compared to CBA-PVI. Obesity was associated with increased radiation exposure. Both techniques were comparably safe. The 1-year AF-freedom was similar in overweight and obese patients.
使用脉冲场消融(PFA)或冷冻球囊消融(CBA)进行肺静脉隔离(PVI)是治疗心房颤动(AF)患者常用的单次治疗技术。接受PVI治疗的超重(体重指数25 - 30kg/m²)和肥胖(体重指数>30kg/m²)患者数量正在增加,但关于这一患者群体的数据有限。
本回顾性分析纳入了连续的体重指数≥25kg/m²且接受PFA或CBA - PVI治疗的AF患者。对两种消融方式的基线特征、手术参数和1年无房颤情况进行回顾性分析和比较。
115例患者(66%为男性,64岁[四分位间距:58 - 71岁],57%超重,43%肥胖)中,68%接受PFA - PVI,32%接受CBA - PVI。接受PFA - PVI治疗的患者造影剂用量(PFA:80ml[四分位间距:60 - 117ml] vs. CBA:130ml[四分位间距:95 - 200ml],P = 0.001)和辐射暴露量(PFA:2196cGy·cm[四分位间距:1398 - 2973cGy·cm] vs. CBA:3239cGy·cm[四分位间距:1288 - 5062cGy·cm],P = 0.009)较低。逻辑回归分析确定肥胖(比值比:5.58,95%置信区间:1.63 - 19.06;P = 0.006)和CBA - PVI(比值比:12.93,95%置信区间:3.51 - 47.68;P = 0.001)与辐射暴露增加相关。两种技术安全性相当(PFA:4% vs. CBA:0%;P = 0.3)。中位随访时间为145天[四分位间距:103 - 294天]。超重患者(82%)和肥胖患者(67%)1年后无房颤情况相似(风险比:0.61;95%置信区间:0.29 - 1.28;P = 0.19),PFA - PVI患者和CBA - PVI患者也相似(76% vs. 76%,风险比:1.37;95%置信区间:0.63 - 2.99;P = 0.42)。
与CBA - PVI相比,接受PFA - PVI治疗的超重和肥胖患者造影剂用量较低。肥胖与辐射暴露增加相关。两种技术安全性相当。超重和肥胖患者1年后无房颤情况相似。